Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 29, 2009

Lonza Launches Cells on Demand Services for Cell Culture and Transfection

  • Lonza launched Cells on Demand™ Cell Culture and Transfection Services as a new offering for assay-ready cells for cell-based screening. Lonza says the new services cover bulk cell production, transfection services, cell-isolation services, and media production.

    Large-scale manufacturing is offered for cell lines, transfected cells, and primary cells including Clonetics® primary cells and Poietics® stem cells. The transfection services include expertise with Amaxa® Nucleofactor® technology for generating stable clones and transiently transfected cells as well as Nucleofection® Protocol Optimization and small-scale protein production.



Related content

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »